You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
博暉創新(300318.SZ):已在雲南曲靖投建成了1500噸加工能力的血制生產工廠
格隆匯 07-14 08:08

格隆匯7月14日丨博暉創新(300318.SZ)近期在接待機構投資者調研時表示,公司目前有3個血液製品生產企業,分別是位於河北石家莊的博暉生物製藥((河北)有限公司(((河北博暉”),位於河北廊坊的博暉生物製藥股份有限公司(((廊坊博暉”),以及位於廣東汕頭的廣東衞倫生物製藥有限公司(((廣東衞倫”)。另外,公司已經在雲南曲靖投資建成了1500噸加工能力的血制生產工廠,目前正在進行血制生產資質遷址至雲南工廠的相關工作。同時,為了拓展血漿資源和市場區域,在內蒙古呼和浩特籌建了一個新的血液製品生產工廠,未來待內蒙古工廠建成後,計劃將旗下的一個血制生產資質遷至內蒙古工廠。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account